The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just read it Alarno. As you say, nothing new.
Business update has been released. Nothing new but good to here from the board.
blood testing is not a niche. private blood testing sector will come up heavily from my perspective. NHS needs to outsource this stuff to the private sector otherwise it will totally collapse.
Just wait an see. And don't forget that there is already a market of nearly 60mio blood test per year done by the private sector. That's only 10% of the whole market.
The reason for the slower growth of the network has be the NHS topic. Some of the pharmacies only want to work with a NHS listed and proven partner. I thought this is through.
This thin g will ramp up until the end of the year. Give them until September to set everthing up for the year end sprint. And there is still a lot covid testing in the market especially for tourism.
That's the hope I'm sure....however, some way off that.
Unless the NHS was to out source because it is cheaper?
Alarno. The reason the blood tests are not the success they thought they would be is because no-one has any money to splurg on private blood testing when you can get it for nowt on the NHS. The reason the covid testing was so successful is because people were forced to test if they wanted to travel. No-one is forced to take a private blood test. Very little appetite for this sort of thing in the current climate. Watch this space for a sudden change in direction once more. Sell all the assets, fold the 'company' and give us all a bit of our money back would be the best bet.
Sianhan. I possed that very question, with that turn of phrase last week to the company...and I still can't enlighten you. Those of us in from the start have been taken on a massive ride...robbed is about right. The company we first invested in now is unrecognisable from what's left today. I've all but given up. I had built up a stash of 100000 shares at average 6p. I now have 33000 at an average of 19p. After this wonderful move again I will now have 3300 at God knows what average?! Daylight robbery.
Can anyone here enlighten me as to why the bod are doing a reverse split with our shares. At 10 shares held for 1 new one.
I’ve been here from the start. Shareholders have already been hit with a take over that reduced our shares. Seems like daylight robbery to me.
Bloods are not the niche that they thought they would be. Thats why we are still on 235 clinics. If the money was coming in we would have scaled up quicker. Unless I am wrong and we have a corporate client on board that is waiting to be announced.
We definitely need a new direction now that covid has slowed. Will blood tests be our new niche? Definitely isn't CBD anymore. Not a mention of money generated through CBD sales.
Quire right Alarno. I remember when we were going to give horses CBD!! Where have those days gone?! Haha.
On a more serious note, not a single mention of CBD in this RNS....very telling. Looks like that's being abandoned quietly.
I agree but it all feels very sombre. We should be celebrating such results and yet it feels like a failure. We have a good cash position and we are in a developing market. We need to hear more than just the results. What are the new projections etc. Lift the spirits please. At one point we were going after so much, now it just seems to be a muted affair. Come on Geremy give us the plan.
results are as expected. nothing more to say.
A detailed view will hopefully possible when the uploaded them on goodbodyhealth
trading will be suspended until the beginning of next week.
During that time there will be the RS and the move to Guernsey. Have a nice weekend.
from my understanding, the consolidation is a different topic and will be done right afterwards. Should be possible that it is not tradable during the consolidation. Consolidation could be possible this week already.
Next week the move to Guernsey and getting a new "GG-ISIN" possible. But I don't know that in particular.
Does anyone know if consolidation will be completed during suspension or is that later?
https://ceo.ca/@newsfile/cse-bulletin-delist-goodbody-health-inc-gdby
In parallel to that the AQSE suspended GDBY share trading in UK based on the announcement that GDBY will possibly do it around the 16th. But AQSE didn't asked GDBY about confirmation. :D
Thanks Lebad. Good work.
just fyi, I just shared the questions with GDBY. Now, we will wait.
Have a nice weekend
thx @alarno for sharing those questions. those are matching with some questions from German shareholders. I will put them on the list.
Are the projected numbers for clinics and revenue too optimistic?
What ever happened to the development of the app?
Why has the communication become so poor.
Is there going to be a buy back of shares?
Do we have any partners for our cbd? For example WH Smith. What happened to that partnership?
Is the Poland site still operational? And if so are we losing money by having it?
How are we going to fend off the competition for blood tests?
What can we look forward to as shareholders of the business.
Is 10p still a realistic target price set by Arden?
Why have we stopped doing news updates?
Will there be a cash raise? Any institutional investors etc.
I am sure the other guys have more questions for you.
I#m still searching for more questions. ;D
@Barravelli
THey are only allowed to buy back max 10% per year. Currently they could buyback those 18mio shares for a real low amount of money. but it would not really help for the future. so the RS is the better opportunity from my perspective.
@alarno
I totally agree. But we should not expect too much from Q2 revs. Heavily decreasing Covid testing revs, slowly increasing blood test revs, liabilities to be covered, nearly no CBD sales. *fingers crossed* but there must also be something else in the background.
In one interview Geremy stated that he was embarrassed by the share price and told the long term holders to hang in there. I believe something is on its way. I have waited this long so a while longer won't make a difference. Q2 results will be the real indication of what is going on.